US military to resume testosterone screening despite medical concerns

The United States Department of Defense will resume a controversial testosterone deficiency screening programme for military personnel aged 30 and above, following a temporary pause in the initiative. The decision comes as the military maintains that the testing programme serves important health and readiness objectives across its ranks.

However, medical professionals have raised significant concerns about the mandatory screening requirements. Experts have characterised the testing as unnecessary for many service members and have warned that it carries potential for causing harm. Critics argue that the programme lacks sufficient clinical justification and may expose personnel to unwarranted medical interventions.

The Pentagon's decision to proceed indicates the military prioritises its assessment of the programme's value despite the medical community's reservations. Defence officials have not detailed specific changes or safeguards being implemented to address the concerns raised by health experts.

The testosterone screening programme represents one of several health initiatives introduced within the military healthcare system in recent years. The move reflects ongoing debates about the appropriate scope and necessity of preventive screening programmes in military populations.